Other GLP-1 Analogs: Short-Acting vs Long-Acting After exenatide and liraglutide, several other GLP-1 receptor agonists were introduced in the early-to-mid 2010s
5 Market outlook Eli Lillys oral non-peptide GLP-1RA orforglipron is advancing through the ACHIEVE Phase III program, with Lilly signaling regulatory submissions for obesity in 2025 and type 2 diabetes in 2026, following positive results from both Phase 2 obesity (GZGI) and Phase 3 T2DM (ACHIEVE-1) trials
I also bought some pineapple to keep in the fridge for its bromelain and vitamin C, and stocked my pantry with Cure Hydrating Electrolyte Mix ($18)
Health plans may steer a drug into the pharmacy benefit to leverage rebates, or into the medical benefit to take advantage of site-of-care differences
Lemairamin, isolated from the Zanthoxylum plants, alleviates pain hypersensitivity via spinal alpha7 nicotinic acetylcholine receptors
The lizard can shut its metabolism down for months